ALFA Filings
Every announcement, straight from the exchange
Every Metropolis Healthcare business update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Metropolis Healthcare provided a business update for Q2FY27, reporting 15% Y-o-Y revenue growth driven by increased patient and test volumes alongside improved EBITDA margins.
Metropolis Healthcare Limited submitted its Business Responsibility and Sustainability Report for the financial year 2025-26, as required by SEBI (LODR) Regulations.
Metropolis Healthcare reported ~23% Y-o-Y consolidated revenue growth for Q4FY26, driven by the TruHealth wellness and specialized testing segments. B2B and B2C channels grew 30% and 19% respectively. Organic revenue increased ~14.5%, supported by improved EBITDA margins and volume growth across diagnostic segments.